Skip to main content
Open Access Publications from the University of California


UC San Francisco Previously Published Works bannerUCSF

Genetic advances uncover mechanisms of chemotherapy-induced peripheral neuropathy.

  • Author(s): Chua, KC
  • Kroetz, DL
  • et al.

Published Web Location

Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting toxicity experienced in 30-40% of patients undergoing treatment with various chemotherapeutics, including taxanes, vinca alkaloids, epothilones, proteasome inhibitors, and thalidomide. Importantly, CIPN significantly affects a patient's quality of life. Recent genetic association studies are enhancing our understanding of CIPN pathophysiology and serve as a foundation for identification of genetic biomarkers to predict toxicity risk and for the development of novel strategies for prevention and treatment.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
Current View